George Kemble
Chairman at SAGIMET BIOSCIENCES INC.
Net worth: 833 505 $ as of 30/05/2024
George Kemble active positions
| Companies | Position | Start | End |
|---|---|---|---|
| SAGIMET BIOSCIENCES INC. | Chairman | 23/10/2022 | - |
| Director/Board Member | 30/09/2015 | 23/10/2022 | |
| Chief Executive Officer | 30/09/2015 | 23/10/2022 | |
| Chief Tech/Sci/R&D Officer | 14/08/2011 | 23/10/2022 | |
| President | 30/09/2015 | 23/10/2022 |
Career history of George Kemble
Former positions of George Kemble
| Companies | Position | Start | End |
|---|---|---|---|
MedImmune LLC
 MedImmune LLC BiotechnologyHealth Technology MedImmune LLC develops medicines for the prevention and treatment of infectious diseases such as cancer and immune system disorders. It offers solutions in the areas of monoclonal antibodies and vaccines for infection, oncology, respiratory disease and inflammation, cardiovascular diseases, and neuroscience. The company was founded by Wayne T. Hockmeyer in 1988 and is headquartered in Gaithersburg, MD. | Chief Tech/Sci/R&D Officer | - | - |
MedImmune Vaccines, Inc.
 MedImmune Vaccines, Inc. BiotechnologyHealth Technology MedImmune Vaccines, Inc. develops, manufactures and markets live vaccines. Its developed vaccine is inhaled FluMist. The company was founded on April 15, 1992 and is headquartered in Mountain View, CA. | Corporate Officer/Principal | - | - |
| LigoCyte Pharmaceuticals, Inc. | Director/Board Member | 28/01/2010 | - |
Training of George Kemble
| Santa Clara University | Undergraduate Degree |
| Stanford University | Doctorate Degree |
Statistics
International
| United States | 7 |
Operational
| Director/Board Member | 2 |
| Chief Tech/Sci/R&D Officer | 2 |
| Undergraduate Degree | 1 |
Sectoral
| Health Technology | 5 |
| Consumer Services | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| SAGIMET BIOSCIENCES INC. | Health Technology |
| Private companies | 3 |
|---|---|
| LigoCyte Pharmaceuticals, Inc. | Health Technology |
MedImmune LLC
MedImmune LLC BiotechnologyHealth Technology MedImmune LLC develops medicines for the prevention and treatment of infectious diseases such as cancer and immune system disorders. It offers solutions in the areas of monoclonal antibodies and vaccines for infection, oncology, respiratory disease and inflammation, cardiovascular diseases, and neuroscience. The company was founded by Wayne T. Hockmeyer in 1988 and is headquartered in Gaithersburg, MD. | Health Technology |
MedImmune Vaccines, Inc.
MedImmune Vaccines, Inc. BiotechnologyHealth Technology MedImmune Vaccines, Inc. develops, manufactures and markets live vaccines. Its developed vaccine is inhaled FluMist. The company was founded on April 15, 1992 and is headquartered in Mountain View, CA. | Health Technology |
- Stock Market
- Insiders
- George Kemble
- Experience
